Work

A Phase I Study of a Daily ×3 Schedule of Intravenous Vinorelbine for Refractory Epithelial Ovarian Cancer

Year: 1998

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1006/gyno.1998.5130

Authors: David M. Gershenson, Thomas W. Burke, Mitchell Morris, Robert C. Bast, Al Guaspari, John Hohneker, J.Taylor Wharton

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2037908836

FWCI: 3.604

Cites: 19

Cited by: 37

Related to: 10